Pioneers in Neuroscience


Driven by our commitment to patients and our passion for neuroscience, Biogen remains focused on furthering Alzheimer’s disease research and treatment. Visit our resource center for the latest information, news and stories about Alzheimer’s disease at Biogen.

Biogen updates delivered to your inbox
The impact of genetic ALS

With the passing of his uncle and gradual confirmation that several family members carry genetic mutations which can lead to amyotrophic lateral sclerosis (ALS), Jeremy began looking into educational information around genetic ALS.

The Alzheimer’s Puzzle: Unlocking the Science 

From imaging that enables us to see amyloid and tau in the brain to determine whether potential therapeutics reach their targets, to one big leap of faith that antibodies can get into the brain, our scientists are not giving up on solving the Alzheimer’s puzzle.

3/3/21 4:06 PM EST
Biogen to Webcast Aducanumab Presentations from AD/PD 2021 Virtual Conference on March 9-13, 2021
View all news
Diversity, Equity and Inclusion

Biogen is committed to the power of diversity – in our organization and among our patients and customers. Diversity is an essential asset of complementary strengths and perspectives from which all benefit, and which must unite us, not divide us.


Thank you to the many front-line workers and organizations working tirelessly to help in these difficult days. Please find updates on Biogen’s response to COVID-19 here.

Where Science Meets Humanity

Science that transforms patient lives. Science that seeks to solve societal problems. Science that acts with purpose. Science that is inspired by the diversity and passion of our people. Discover where science meets humanity at Biogen.

Follow us on social media